Compare
Orforglipron vs Semaglutide
The honest difference
Both are licensed UK medicines for weight loss. Orforglipron is a daily pill, but it gave less weight loss than the strongest injections.
Peptide
Orforglipron
Grade A: approved / strong human evidence
Why people buy it
People take it to lose weight. It is a daily pill, not an injection. In the UK it is also licensed for type 2 diabetes.
Bottom line
A real, licensed weight-loss pill that works, though less strongly than the best injections. Get it from a doctor or pharmacy, not a website.
- UK status
- Licensed UK medicine, prescription-only (POM). The MHRA authorised orforglipron as Foundayo (Eli Lilly) on 10 August 2026, the first authorisation in Europe, for weight management in adults with a BMI of 30 or more, or 27 to 30 with at least one weight-related condition, alongside diet and activity, and for type 2 diabetes that is not well controlled.
- Sport / WADA
- Not prohibited. GLP-1 receptor agonists are not on the WADA 2026 Prohibited List, and as an approved medicine orforglipron does not fall under S0 (non-approved substances).
Peptide
Semaglutide
Grade A: approved / strong human evidence
Why people buy it
This is the real medicine in Ozempic and Wegovy. People take it to lose weight or to control type 2 diabetes.
Bottom line
A proven medicine that really works. Get it from a doctor or pharmacy, not a website.
- UK status
- A fully licensed UK medicine, prescription-only (POM), regulated by the MHRA. Marketed as Ozempic and Rybelsus (type 2 diabetes) and Wegovy (chronic weight management).
- Sport / WADA
- Not prohibited by WADA; semaglutide and GLP-1 receptor agonists are not on the WADA Prohibited List.
Grades are about evidence in humans, not about whether something is right for you. Nothing here is dosing advice. Talk to a qualified clinician before any health decision.
More comparisons